2021
DOI: 10.3390/ncrna7030047
|View full text |Cite
|
Sign up to set email alerts
|

Non-Coding Variants in Cancer: Mechanistic Insights and Clinical Potential for Personalized Medicine

Abstract: The cancer genome is characterized by extensive variability, in the form of Single Nucleotide Polymorphisms (SNPs) or structural variations such as Copy Number Alterations (CNAs) across wider genomic areas. At the molecular level, most SNPs and/or CNAs reside in non-coding sequences, ultimately affecting the regulation of oncogenes and/or tumor-suppressors in a cancer-specific manner. Notably, inherited non-coding variants can predispose for cancer decades prior to disease onset. Furthermore, accumulation of a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 356 publications
(394 reference statements)
0
8
0
Order By: Relevance
“…In the case of cancer non-coding SNPs, localization within the UTRs is considered to be especially damaging. The identified variations in these regions are found to perturb the structure of miRNA and thereby the interactions with other miRNAs and gene products [34][35][36]. UTRs maintain post-translation regulation in gene expression, any variation in the UTR region can be linked to severe pathologies [37,38].…”
Section: Discussionmentioning
confidence: 99%
“…In the case of cancer non-coding SNPs, localization within the UTRs is considered to be especially damaging. The identified variations in these regions are found to perturb the structure of miRNA and thereby the interactions with other miRNAs and gene products [34][35][36]. UTRs maintain post-translation regulation in gene expression, any variation in the UTR region can be linked to severe pathologies [37,38].…”
Section: Discussionmentioning
confidence: 99%
“…There are several factors for the poor performance of predictive computational models of functional non-coding DNA variants, such as the inadequate understanding of the molecular feature of gene regulation, the inaccurate estimation of the DNA variant impact on target gene expression, the significance of DNA sequence conservation in vertebrates on the functional regulatory element, and enrichment of transcription factor binding sites. In cancer diseases, risk prediction based on non-coding variants remains challenging due to the diversity of the non-coding regions among individuals, the inability to distinguish driver and passenger mutations, and the current lack of understanding of the underlying mechanism associated with functional non-coding variants [35]. Hence, proving an underlying biological mechanism for disease development, such as the functional non-coding SNPs.…”
Section: Discussionmentioning
confidence: 99%
“…Due to the nature of RNAseq platforms only capturing variants in transcribed regions, rarer variants that fall in crucial functional regions such as promoter and enhancer regions go unaccounted for 22 . These rare, non-transcribed variants are mostly linked to increased risk of various diseases and are enriched within expressed quantitative trait loci (eQTLs) [23][24][25] , therefore rendering RNAseq variant calling suboptimal for eQTL analysis. Thus, our study should not be utilized as a one-to-one replacement for conventional genotyping array or whole genome sequencing.…”
Section: Discussionmentioning
confidence: 99%